Cancer Topics

National Young Adult Cancer Awareness Week® 2013
Apr
01
2013

30 years ago this week, I was a young adult diagnosed with breast cancer.  If you’re a young adult with cancer today, it would be hard to imagine what it was like in 1983.  Even the phrase, young adults with cancer, often provoked a reaction of surprise and dismissal.  While feelings of isolation and alienation [...]

Read More
The Group Room Interviews at the 2012 San Antonio Breast Cancer Symposium
Mar
04
2013

  Advocacy and educational support provided in part by:

Read More
Stefan Gluck, MD: Personalized Medicine and Tissue Collection For Cancer Research
Mar
04
2013

Dr. Stefan Gluck sits down with Selma Schimmel and The Group Room at the 35th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS).  They discuss personalized medicine as well as the need for more efficient tissue and biospecimen collection for cancer research. Stefan Gluck, MD is a Professor of Medicine, University of Miami, Associate Division [...]

Read More
Christopher Twelves, MD: Comparing Eribulin and Capecitabine
Mar
04
2013

Dr. Christopher Twelves sits down with Selma Schimmel and The Group Room at the 35th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS).  They discuss the results of the Phase III clinical trial comparing capecitabine (Xeloda) and eribulin (Halaven).  The trial showed trends toward the superiority of eribulin in this setting but the results were [...]

Read More
Joanne Mortimer, MD: Functional imaging Of HER2-positive Metastatic Breast Cancer
Mar
04
2013

Dr. Joanne Mortimer sits down with Selma Schimmel and The Group Room at the 35th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS).  They discuss research being conducted at the City Of Hope Cancer Center on the functional imaging of HER2-positive metastatic breast cancer. Joanne Mortimer, MD is the Vice Chair, Medical Oncology & Therapeutics [...]

Read More
Richard S. Finn, MD: The Combination Of PD 0332991 and Letrozole Phase II Results
Mar
03
2013

Dr. Richard S. Finn sits down with Selma Schimmel and The Group Room at the 35th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS).  They discuss  the combination of PD 0332991 and letrozole phase II clinical trial results. Richard S. Finn, MD is Associate Professor at the Jonsson Comprehensive Cancer Center at UCLA. Advocacy and [...]

Read More
Martine Piccart, MD, PhD: Can Patients and Advocates Help With Tissue and Biospecimen Collection?
Mar
03
2013

Dr. Martine Piccart sits down with Selma Schimmel and The Group Room at the 35th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS).  They discuss how cancer patients and advocates can help lead the way for tissue and biospecimen collection for cancer research. Martine Piccart, MD, PhD is the current President of the European Society [...]

Read More
Martine Piccart, MD, PhD: No Benefit in Extending Herceptin in HER2 Breast Cancer
Mar
03
2013

Dr. Martine Piccart sits down with Selma Schimmel and The Group Room at the 35th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS).  They discuss the results of a study she authored for patients with human epidermal growth factor receptor 2 (HER2)–positive early–stage breast cancer — one year of adjuvant trastuzumab (Herceptin) should remain the [...]

Read More
Edith Perez, MD: Anti-HER2 Therapies
Mar
03
2013

Dr. Edith Perez sits down with Selma Schimmel and The Group Room at the 35th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS).  They discuss her recent research with Anti-HER2 therapies presented at SABCS 2012. Edith A. Perez, MD is Deputy Director, Mayo Clinic Cancer Center — Group Vice Chair, Alliance for Clinical Trials in [...]

Read More
Advocacy In Action: Issues For Young Women With Metastatic Breast Cancer
Mar
03
2013

Vital Options International presents Advocacy in Action bringing together influential leaders of the cancer advocacy community to address:  Personalized Medicine: What it means, its relevance for patients, collection of tissue specimens, and a discussion on metastatic breast cancer in young women.  Part 4 of 4. Joining Vital Options Founder and CEO, Selma Schimmel, as co-hosts [...]

Read More